Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis

Limited information exists regarding the optimal dose of posaconazole delayed-release tablet for the treatment of invasive mold infection. Here, we report the case of a previously healthy 44-year-old Thai man who developed coexisting invasive pulmonary aspergillosis and mucormycosis following a car...

Descripción completa

Detalles Bibliográficos
Autores principales: Leelawattanachai, Pannee, Montakantikul, Preecha, Nosoongnoen, Wichit, Chayakulkeeree, Methee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497849/
https://www.ncbi.nlm.nih.gov/pubmed/31114213
http://dx.doi.org/10.2147/TCRM.S203625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497849/
https://www.ncbi.nlm.nih.gov/pubmed/31114213
http://dx.doi.org/10.2147/TCRM.S203625

Ejemplares similares